Posts by Muana Minkoué
Bewe’s Biopôle journey comes full circle with Pre-Clinical Top-Up
Biopôle SA is delighted to announce that Bewe has been awarded the Pre-Clinical Top-Up, marking the next phase of a long-standing relationship between our campus and the University of Fribourg spin-off, which is developing a neuroscience-based digital intervention for unhealthy food cravings. Indeed, Bewe previously participated in Biopôle’s Investment Readiness Programme and Start-Up Fund, which…
Read MoreSpineart and eCential Robotics receive FDA clearance for the PERLA® TL application
Spineart, a global fast-growing company in spine surgery innovation, and eCential Robotics today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the PERLA® TL application (PERLA® by Spineart app) for use with the eCential® Op.n® Navigation and Robotic-Assisted Platform. Building on the previously established compatibility between PERLA® and the…
Read MoreAdaptyv raises $40M Series A to build the automated lab for agentic biology
The Biopôle-based startup announced a $40M Series A funding round to build the automated lab for agentic biology, led by Highland Europe, with existing investors Ace Ventures, ByFounders and Y Combinator doubling down. Last week, they shared their work with Anthropic. Claude designed proteins, sent them to Adaptyv‘s automated wet lab, and got real experimental data…
Read MoreDeep Dive – Ready to Sell? Navigating the commercial transition
Join us for a Deep Dive focused on navigating the commercial transition on Monday 5 October 2026 at Biopôle, in Lausanne. BioAlps and the Biopôle are delighted to present this exclusive event dedicated to the commercial transition. Moving from the development stage to the sales stage is one of the most demanding transitions a life sciences…
Read MoreSpineart Announces FDA Approval ofBAGUERA® C Cervical Disc
Spineart announces that the BAGUERA® C cervical disc has received FDA approval for 1 and 2 contiguous levels, expanding access in the United States to a motion-preserving solution for patients suffering from cervical disc disease. As one of Spineart’s foundational technologies and a cornerstone of its cervical portfolio, BAGUERA® C brings nearly two decades of international clinical experience…
Read MoreSubscribe to our newsletter
FutureHealth Lausanne announced its Innovation Challenge 2025 winners
The 15 winners of the FutureHealth Lausanne 2025 Innovation Challenge – selected by the FutureHealth Ecosystem – have been unveiled. For the first time, FutureHealth Lausanne carried out an Innovation Challenge – powered by the Canton of Vaud, Biopôle, BioAlps and the city of Lausanne. Health Innovators had the opportunity to showcase their…
Read MoreOculis Upsized Loan Facility to Access up to CHF 100 million
Oculis Holding AG, a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant unmet medical needs, announced that it has amended its loan facility (the “Amended Loan Agreement”) with funds and accounts managed by BlackRock (the “Lender”). The Amended Loan Agreement replaces the prior loan agreement between Oculis and…
Read MoreCampus Biotech: At the heart of networked innovation
A shared perspective on two podcast episodes at the heart of Geneva’s scientific life. How can academic research, technological innovation, entrepreneurship, and patient impact come together and speak the same language?Through the first two episodes of the Where Science Talks podcast, Campus Biotech gives voice to the people shaping a vibrant and interconnected…
Read MoreThree Geneva-based startups receive funding from the FONGIT Innovation Fund (FIF)
Three life sciences projects from Geneva have been awarded funding through the FONGIT Innovation Fund (FIF), underscoring the canton’s strong commitment to driving innovation and advancing sustainable solutions. CHF 100,000 FIF Seed Loan awarded to BrainScape Medical: Creating Solutions for Optimised Brain Health Management BrainScape Medical, a Geneva-based life sciences startup supported by…
Read More